PGP and early-onset autosomal dominant Alzheimer disease: Treatment of a mouse model of Alzheimer’s disease with nocodazole not only restored P-gp protein expression levels to that of wild-type mice and enhanced P-gp transport activity, but also lowered overall human Aβ40 and Aβ42 levels in the brain [109].